AzTrials
AzTrials

Overweight and ObesityPENNCT05876260

Effect of Post-exercise Nutrition on Glycemia in Women

A study testing Greek yogurt, Carbohydrate-based study supplement and Exercise in people with Overweight and Obesity, run by University of Toronto at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to assess whether post-exercise Greek yogurt following a single session of aerobic exercise improves metabolic and musculoskeletal health in women with overweight/obesity. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Overweight and Obesity
What is being tested?
Greek yogurt, Carbohydrate-based study supplement and Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteCanada
Study dates
24 May 2023to 1 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 18-45 yrs
  • BMI ≥27 kg/m2
  • Elevated waist circumference (≥88 cm)
  • ≤2 structured exercise sessions/week
  • Weight stable (within ± 2kg for at least 6 months)
  • Experiencing regular natural menstrual cycles
  • Non-smoker

Who cannot join

  • Allergy to dairy foods
  • Diagnosed lactose intolerance or an aversion to foods provided during the study (e.g., post-exercise snacks)
  • Previous history of cardiovascular or metabolic disease
  • The use of medication for managing blood glucose or lipid metabolism
  • Current use of oral contraceptives or use within the last 3 months
  • Irregular menstrual cycles (<21 days or >35 days)
Show all 10Show fewer
  • Pregnant or lactating
  • Recreational tobacco or cannabis use
  • Inability to perform the study exercise protocols
  • Actively engaging in a low-carbohydrate diet (e.g., ketogenic, Atkins).

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Jenna Gillen

    Toronto, Ontario, M4K 1V2

Other trials in Canada

About this study

Official title: Influence of Post-exercise Greek Yogurt on 24 h Glycemic Control in Women With Overweight/Obesity

The purpose of this study is to assess whether post-exercise Greek yogurt following a single session of aerobic exercise improves metabolic and musculoskeletal health in women with overweight/obesity.

Read the detailed description

Following the acquisition of informed consent, eligibility to participate in the study will be determined using questionnaires. Participants will undergo baseline testing at our laboratory at the University of Toronto to determine cardiorespiratory fitness, body composition and undergo exercise familiarization.

Eligible participants will be assigned, in a random order, to two metabolic trials approximately 4 weeks apart that involve 4 days of controlled diet and exercise. Each trial takes place over 4 days, but participants are not required to come to the laboratory on all days. The two trials involve: 1) Exercise + Greek Yogurt (GY) 2) Exercise + a carbohydrate-based study supplement (SS).

During the 4 day trials, participants consume controlled diets and the study supplements (GY and SS). On 1 of these days participants will perform exercise in our lab followed by the consumption of GY or SS. Various outcomes will be measured throughout the trial, including glycemic control (via continuous glucose monitoring), fat oxidation, appetite and health outcomes in blood samples.

Throughout the duration of the study, participants will be asked to maintain their habitual diet and physical activity patterns, and maintain their current body weight.

Being tested
Greek yogurt, Carbohydrate-based study supplement, Exercise
Keywords
women, glycemic control, exercise
Medical subject headings
Overweight, Obesity, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Greek yogurtBehavioural

    Following 2 days of controlled diet, participants will consume greek yogurt following high-intensity interval exercise

  • Carbohydrate-based study supplementBehavioural

    Following 2 days of controlled diet, participants will consume a carbohydrate-based study supplement following high-intensity interval exercise

  • ExerciseBehavioural

    Following 2 days of controlled diet, participants will perform high-intensity interval exercise following an overnight fast

Study groups in NCT05876260
Study groupRoleWhat they receive
High-intensity interval exercise and post-exercise Greek yogurt (HIIE+GY)ExperimentalParticipants will consume greek yogurt following a single session of exercise
Receives: Behavioral: Greek yogurt; Behavioral: Exercise
High-intensity interval exercise and post-exercise carbohydrate study supplement (HIIE +SS)Active comparatorParticipants will consume a carbohydrate-based study supplement following a single session of exercise
Receives: Behavioral: Carbohydrate-based study supplement; Behavioral: Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postprandial glycemia

    Postprandial glucose exposure assessed using continuous glucose monitoring

    Measured: 24 hour post-exercise

Secondary outcomes (14)
  1. 24 hours average glucose

    Average glucose concentration over 24 hours

    Measured: 24 hours post-exercise

  2. Nocturnal glucose

    Overnight glucose concentration

    Measured: 6-8 hours

  3. Nocturnal glucose

    Overnight glucose exposure (area under the curve)

    Measured: 6-8 hours

  4. Glycemic variability

    Continuous overall net glycemic action (CONGA)

    Measured: 24 hours

  5. Glycemic variability

    Standard deviation (SD)

    Measured: 24 hours

  6. Glycemic variability

    Coefficient of variation (%CV)

    Measured: 24 hours

  7. Post-exercise fat oxidation

    Fat oxidation assessed with indirect calorimetry

    Measured: 1, 2 and 3 hours post-exercise

  8. Fasting glucose concentration

    Venous blood sampling

    Measured: 24 hours post-exercise

  9. Fasting insulin concentration

    Venous blood sampling

    Measured: 24 hours post-exercise

  10. Fasting insulin resistance

    Homeostasis Model Assessment (HOMA2)

    Measured: 24 hours post-exercise

  11. Bone metabolism

    Serum concentration of CTX

    Measured: 30, 90, and 180 minutes and 24 hours post-exercise

  12. Bone metabolism

    Serum concentration of OPG

    Measured: 30, 90, and 180 minutes and 24 hours post-exercise

  13. Bone metabolism

    Serum concentration of RANKL

    Measured: 30, 90, and 180 minutes and 24 hours post-exercise

  14. Bone metabolism

    Serum concentration of OC

    Measured: 30, 90, and 180 minutes and 24 hours post-exercise

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 May 2023
  2. Study start24 May 2023
  3. Primary completion1 May 2024
  4. Study completion1 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05876260
Sponsor's protocol ID
42756-3
Acronym
PEN
Status last verified
May 2024
First submitted
5 May 2023
Last updated
7 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Gagnon S, Govette A, Karavetian M, Bailleul C, Klentrou P, Gillen J, Josse A. Acute effects of Greek yogurt consumption on bone status indices following high-intensity interval exercise in premenopausal females with obesity: a secondary analysis from a randomized crossover trial. Appl Physiol Nutr Metab. 2026 Jan 1;51:1-15. doi: 10.1139/apnm-2026-0016.

    PubMed 42561457

Questions about this trial

What is this clinical trial studying?

A study testing Greek yogurt, Carbohydrate-based study supplement and Exercise in people with Overweight and Obesity, run by University of Toronto at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postprandial glycemia (time frame: 24 hour post-exercise). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05876260, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in